UNC45B Antibody

What is UNC45B and why is it important in research?

UNC45B (unc-45 homolog B) is a co-chaperone protein essential for proper folding and accumulation of type II myosins. The protein consists of three tetratricopeptide repeat motifs at the N-terminus that form a complex with heat shock protein 90 (HSP90), a central region conserved in all Unc-45 proteins, and a C-terminal Unc-45/Cro1/She4 (UCS) domain . UNC45B is primarily expressed in striated muscle, where its muscle myosin chaperone activity depends on HSP90 acting as a co-chaperone . It plays crucial roles in sarcomere formation during muscle cell development and is necessary for normal early lens development . Research on UNC45B antibodies enables scientists to investigate muscle development, sarcomeric organization, and related pathologies.

What are the validated applications for UNC45B antibodies?

UNC45B antibodies have been validated for several applications in research:

It's recommended to titrate these antibodies in each testing system to obtain optimal results, as effectiveness can be sample-dependent . Anti-UNC45B antibodies have been successfully used to detect the protein in human, mouse, and rat samples .

What is the molecular weight of UNC45B and how is this relevant for antibody validation?

UNC45B has a calculated molecular weight of approximately 104 kDa (931 amino acids), though the observed molecular weight in experimental conditions is typically around 95 kDa . This difference between calculated and observed molecular weights is important for antibody validation. When performing Western blot analysis, researchers should expect to see a band at approximately 95 kDa, and any significant deviation might indicate non-specific binding or protein degradation. The molecular weight validation is crucial when studying UNC45B mutations or when examining protein expression levels in muscle biopsy samples from patients with muscle disorders .

What is the structure of UNC45B and how does it relate to its function?

UNC45B protein consists of three distinct domains, each with specific functions:

• N-terminal domain: Contains three tetratricopeptide repeat (TPR) motifs that interact with HSP90

• Central domain: Region of unknown specific function but conserved in all Unc-45 proteins

• C-terminal UCS domain: Responsible for binding to myosin and essential for chaperone activity

The structure is critical for UNC45B's function as a molecular chaperone. The protein forms oligomers through its central domain, which enables efficient binding and folding of myosin molecules . Structural analyses using PyMOL and SWISS-MODEL have demonstrated that mutations in conserved amino acids can disrupt the protein's structural stability and myosin-binding capabilities . The UCS domain, in particular, contains highly conserved residues from yeast to humans, indicating its evolutionary importance in myosin folding and muscle function .

How does UNC45B interact with myosin and HSP90 in muscle development?

UNC45B functions as a co-chaperone for HSP90 and is required for proper folding of the myosin motor domain . The mechanism involves:

• The N-terminal TPR domain of UNC45B binds to HSP90

• The C-terminal UCS domain interacts with the myosin motor domain

• Together, UNC45B and HSP90 ensure proper folding and accumulation of type II myosins

• UNC45B forms transient multimers that assist in binding and folding functional myosins

This chaperone activity is crucial during sarcomere formation. In studies using C. elegans and zebrafish models, disruption of UNC45B function leads to defects in myofibrillar organization and muscle function . Importantly, UNC45B is dynamically localized within the sarcomere, typically at the A-band, but abnormal UNC45B variants can show altered localization toward the Z-disk of the sarcomere .

How should I optimize Western blot protocols for UNC45B detection?

For optimal Western blot detection of UNC45B:

• Sample preparation:

  • For muscle tissue: Homogenize with lysis buffer containing 4% SDS, 125 mM Tris-HCL (pH 8.8), 40% Glycerol, 500 μM PMSF, and 100 mM DTT

  • Sonicate samples on ice and centrifuge at 14,000 rpm for 15 min at 4°C

• Electrophoresis and transfer:

  • Use NuPAGE 4%-12% Bis-Tris gels under reducing conditions

  • Transfer to nitrocellulose membrane

• Blocking and antibody incubation:

  • Block with PBS blocking buffer

  • Use UNC45B antibody at dilutions ranging from 1:1000-1:5000

  • Include appropriate controls (e.g., desmin antibody as loading control)

• Detection considerations:

  • Expected molecular weight: ~95 kDa

  • Positive controls: Skeletal muscle tissue from mouse/rat

When studying UNC45B mutations, it's useful to include fractionation steps to assess protein solubility, as some mutations can alter the distribution between soluble and insoluble fractions .

What considerations are important for immunohistochemistry with UNC45B antibodies?

When performing immunohistochemistry (IHC) for UNC45B detection:

• Tissue preparation:

  • For paraffin-embedded tissues: Use antigen retrieval with TE buffer pH 9.0 or alternatively citrate buffer pH 6.0

  • For cryosections: Fix appropriately to preserve protein structure

• Antibody parameters:

  • Recommended dilution range: 1:50-1:500

  • Incubation conditions: Follow specific protocol for the antibody

• Controls and validation:

  • Positive tissue controls: Skeletal muscle shows strong expression

  • Cardiac muscle and lens tissue can also serve as positive controls

• Analysis considerations:

  • UNC45B typically localizes to the A-band of sarcomeres in muscle tissue

  • Mutations can cause abnormal localization patterns

For reliable results, researchers should optimize antibody concentration for their specific tissue samples and detection systems .

How can I effectively use UNC45B antibodies to study protein-protein interactions?

To investigate UNC45B interactions with myosins and other proteins:

• Co-immunoprecipitation (Co-IP):

  • Use anti-UNC45B antibody to pull down protein complexes

  • Analyze immunocomplexes with antibodies against potential interacting partners (e.g., NMIIA, NMIIB, HSP90)

  • For tagged systems, HA-tagged UNC45B can be immunoprecipitated with anti-HA antibody

• Pull-down assays:

  • For protein oligomerization studies, use differentially tagged UNC45B constructs (e.g., His-tagged and HA-tagged)

  • Pull down with Ni-NTA Agarose beads and analyze precipitated complexes

• Quantification and analysis:

  • Quantify immunoblot signals using software like ImageJ (Fiji)

  • Present results as fold-change relative to wild-type interactions

• Interpreting results:

  • Wild-type UNC45B forms transient multimers during myosin binding

  • Mutant forms may show altered oligomerization patterns or binding affinities

This approach has been successfully used to demonstrate that mutations in UNC45B can affect its oligomerization properties and interaction with myosin clients .

What role does UNC45B play in muscle disorders and how can antibodies help in research?

UNC45B is implicated in several muscle-related pathologies:

• Progressive muscle weakness:

  • Bi-allelic variants in UNC45B can cause childhood-onset progressive muscle weakness

  • UNC45B antibodies help detect protein expression levels and localization in patient muscle biopsies

• Sarcomeric organization defects:

  • UNC45B is essential for myofibrillar organization

  • Antibodies can reveal abnormal localization of UNC45B away from the A-band towards the Z-disk in disease states

• Research applications:

  • Compare UNC45B expression levels between control and affected individuals

  • Analyze sarcomere structure in disease models

  • Correlate UNC45B mutations with protein stability and function

Studies using UNC45B antibodies have demonstrated that some pathogenic variants act as hypomorphs with reduced expression, while others maintain normal protein levels but show altered function or localization .

How has UNC45B been implicated in non-muscle disorders?

Beyond muscle disorders, UNC45B has been implicated in:

• Lens development and cataract formation:

  • A missense mutation in UNC45B (c.2413C>T, p.Arg805Trp) has been associated with cataract development

  • This mutation occurs in the highly conserved UCS domain

  • UNC45B is expressed in human embryonic eyes and zebrafish lens

• Research findings:

  • In zebrafish models, UNC45B mutations lead to smaller eyes and accumulation of nuclei in the lens

  • Injection of wild-type human UNC45B RNA can partially rescue lens development in mutant zebrafish

  • Injection of mutant UNC45B RNA into wild-type embryos can recapitulate the lens development defects

These findings suggest a previously unknown role for UNC45B in organ development beyond muscle tissue, expanding the importance of this chaperone in research contexts.

What are effective strategies for investigating UNC45B mutations using antibodies?

To effectively study UNC45B mutations:

• Protein expression analysis:

  • Compare wild-type and mutant UNC45B expression levels using Western blot

  • Perform cycloheximide chase assays to assess protein stability differences

  • Use fractionation to examine soluble vs. insoluble protein distribution

• Localization studies:

  • Use immunofluorescence to compare wild-type and mutant UNC45B localization in muscle cells

  • Co-stain for sarcomeric markers to assess proper localization relative to A-bands and Z-disks

• Functional assays:

  • Analyze myosin client protein levels (e.g., MHC B) in the presence of wild-type or mutant UNC45B

  • Temperature-sensitive mutants can be particularly informative, showing reduced UNC45B levels at restrictive temperatures

• Model systems:

  • Use CRISPR-engineered cell lines or model organisms with UNC45B mutations

  • Perform rescue experiments with wild-type UNC45B to confirm causality

Studies in C. elegans have demonstrated that mutations in conserved residues of the UCS domain result in reduced UNC45 protein levels and consequent reduction in myosin heavy chain B levels at restrictive temperatures .

How can I troubleshoot inconsistent results when using UNC45B antibodies?

When facing inconsistent results with UNC45B antibodies:

• Tissue-specific expression considerations:

  • UNC45B is highly expressed in striated muscle (skeletal and cardiac)

  • Expression in other tissues like lens may be lower and require optimized protocols

  • Ensure appropriate positive control tissues are included

• Antibody validation:

  • Verify antibody specificity using knockout controls or competing peptides

  • Check for batch variations by requesting validation data from manufacturers

  • Consider using multiple antibodies targeting different epitopes of UNC45B

• Protocol optimization:

  • For Western blot: Adjust protein loading (UNC45B may require higher protein amounts in non-muscle samples)

  • For IHC: Test different antigen retrieval methods (TE buffer pH 9.0 vs. citrate buffer pH 6.0)

  • Optimize antibody concentration for each application and tissue

• Sample preparation issues:

  • UNC45B is a relatively large protein (~95 kDa) and may require optimized extraction methods

  • Ensure protease inhibitors are fresh and effective

  • Consider altered solubility of mutant proteins when designing extraction protocols

When studying temperature-sensitive mutants, be especially attentive to temperature control during sample preparation to avoid artifacts .

What advanced techniques can be combined with UNC45B antibodies to gain deeper insights into its function?

For comprehensive investigation of UNC45B:

• Protein structure analysis:

  • Combine antibody-based experiments with protein modeling using tools like SWISS-MODEL and PyMOL

  • Model effects of specific mutations on UNC45B structure and predict functional consequences

• Proximity labeling approaches:

  • Use BioID or APEX2 fused to UNC45B to identify proximal interacting proteins in living cells

  • Validate interactions using co-immunoprecipitation with UNC45B antibodies

• Live cell imaging:

  • Combine immunofluorescence data with live imaging of fluorescently tagged UNC45B

  • Use FRAP (Fluorescence Recovery After Photobleaching) to study UNC45B dynamics in sarcomeres

• Multi-omics integration:

  • Correlate UNC45B antibody staining patterns with transcriptomics and proteomics data

  • Link changes in UNC45B localization or expression to broader cellular responses

• Animal models and human samples:

  • Use UNC45B antibodies to compare protein expression and localization across species (C. elegans, zebrafish, mouse, human)

  • Apply findings from model organisms to human patient samples

These advanced approaches have revealed that UNC45B plays conserved roles in myofibrillar organization from C. elegans to humans, with implications for both muscle function and non-muscle tissues like the developing lens .

What are emerging research areas for UNC45B antibodies?

Several promising research directions are emerging:

• UNC45B in non-muscle tissues:

  • Beyond established roles in muscle and lens, investigating UNC45B in other tissues

  • Exploring potential roles in non-muscle myosin regulation in various cell types

• UNC45B in aging-related sarcomere maintenance:

  • Investigating the role of UNC45B in maintaining muscle integrity during aging

  • Studies suggest UNC45B has an important role in maintaining sarcomere structure and function during adult aging

• Therapeutic applications:

  • Exploring UNC45B modulation as a potential therapeutic approach for certain myopathies

  • Development of more specific antibodies targeting mutant forms of UNC45B

• Structural biology approaches:

  • Using antibodies to isolate and purify UNC45B complexes for structural studies

  • Combining with cryo-EM to understand the chaperone mechanism in detail